I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Ultrasound has been used therapeutically for accelerating fracture healing for the past many years. Ever since its clinical use for the first time, there was a growing interest in this modality of osteoinduction. However, the controversy on the exact mechanism of osteoinduction still continues. The US Food and Drug Administration (FDA) has approved the use of ultrasound in fresh fractures (1994)[@CIT1][@CIT2] and for established nonunions (2000).[@CIT3][@CIT4] The role of chemical messengers like neurotransmitters in osteoinduction has evoked new research interest in this field.[@CIT5]--[@CIT7] In this study, we try to bring out the exact biomolecular mechanism by which ultrasound induces fracture healing. If we could elucidate the exact mechanism of osteoinduction at the cellular or molecular level, we may be able to modify fracture healing as such.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

The study protocol was cleared by the institutional review board. The study was conducted in two phases. In the first phase, we induced fractures of the left tibia in Wistar strains of rats under ether anaesthesia. The fractures were splinted with special plastic splints. The rats were divided into two groups. The first group of 10 rats, defined as test group, was given low-intensity, pulsed ultrasound (30 MW/cm^2^) 20 min a day for 10 days. In the second group, of 10 rats, defined as control group, ultrasound treatment was not offered. Tissue samples and serial radiographs were obtained weekly for 3 weeks from both groups. The tissue samples were taken by aspiration from the fracture site \[Figures [1](#F0001){ref-type="fig"} and [2](#F0002){ref-type="fig"}\].

![Therapeutic ultrasound in test group](IJO-42-444-g001){#F0001}

![Radiological evaluation at 2 weeks. Note the exuberant callus in the test group](IJO-42-444-g002){#F0002}

Cells were taken in the phosphate buffer solution (PBS), and their viability was tested with Trifan blue stain. Then the cells were cultured in Rosewaal Pasteur Memorial Institute (RPMI) medium for 24 h. Radioactive thymidine[@CIT8] incorporation test was done on these cells. The tissue aspirated from the fracture site was incubated with radioactive thymidine, and radioactivity was measured in a scintillation counter. The results of the uptake study in the test and control groups were compared statistically. Cells were again cultured with various neurotransmitter combinations, such as serotonin (5HT), dopamine (D)+, butaclomol (BU), GABA+ bicuculline (BI), and radioactive thymidine incorporation test was done; the results compared between both groups.

In the second phase of the study, 10 patients with fracture of the distal radius (extraarticular simple fractures) were included. Five of these fractures were designated as test group, and the rest five were treated as controls. The test group was subjected to low-intensity, pulsed ultrasound applied at the fracture site 20 min daily for 2 weeks. Those belonging to the control group were not given ultrasound therapy. The patients were assessed radiologically, sonologically, and through cell studies before and after ultrasound therapy exactly as in the first phase. The cytological study was conducted with the aspirate from the fracture site exactly as in the first phase.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

In the first phase of study, there was an increased callus formation in the ultrasound group when assessed radiologically by measuring the dimensions of the callus at the fracture site in the anteroposterior and lateral views using a scale.[@CIT9]--[@CIT11] At the cellular level, there was an increased thymidine incorporation in the ultrasound group, as expressed by the scintillation counts shown in Tables [1](#T0001){ref-type="table"}--[3](#T0003){ref-type="table"}.

###### 

Radioactive thymidine incorporation test expressed in scintillation counts

                Test   Control
  ------------- ------ ---------
  First week    8737   7190
  Second week   8863   6583
  Third week    9285   7814

###### 

Radioactive thymidine incorporation test with neurotransmitters

  Neurotansmitters        1 week   2 week   3 week                 
  ----------------------- -------- -------- -------- ------ ------ ------
  Serotonin               9499     119      6674     6607   8490   7752
  Dopamine + Butaclomol   9510     8622     9613     8061   7582   6161
  GABA + Bicuculline      10403    2451     8916     6447   9030   6228

###### 

Radioactive thymidine incorporation test in cells after administration of 5HT, D+BU and GABA+BI

  Patient   RTI in patients   RTI in cells after 5HT administration   RTI in cells after D + BU administration   RTI in cells after GABA + BI administration                           
  --------- ----------------- --------------------------------------- ------------------------------------------ --------------------------------------------- -------- ------ ------- ------
  1         8750              5679                                    11 006                                     7486                                          11 608   7184   9433    5936
  2         9319              4357                                    79 970                                     6052                                          56 605   7200   70871   5285
  3         7844              4532                                    32 533                                     6573                                          33 832   6943   33062   5487
  4         6567              4578                                    43 453                                     5489                                          41 326   5467   45632   4378
  5         7786              5371                                    39 763                                     6913                                          39 552   4774   37194   5279

RTI: Radioactive thymidine incorporation

In the second phase of the study, there was an increased callus formation when assessed sonologically in the ultrasound group \[[Figure 3](#F0003){ref-type="fig"}\]. And, at the cellular level, there was increased thymidine incorporation in the ultrasound group. By using the radioactive thymidine incorporation test \[[Graph 1](#F0004){ref-type="fig"}\], increased osteoblastic activity was observed when neurotransmitter combinations were added to the cells from fracture site in ultrasound group.

![Difference in callus observed without ultrasound and with ultrasound](IJO-42-444-g003){#F0003}

![Radioactive study after neurotransmitter administration composite comparison. 5HT D + BU GABA + BI](IJO-42-444-g004){#F0004}

These experimental and clinical observations strongly suggest that the radioactive thymidine incorporation was significantly higher in the test group after ultrasound therapy and after neurotransmitter administration.

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Low-intensity, pulsed ultrasound has been proved in previous studies in the literature to significantly enhance fracture healing. In our study, the level of radioactivity[@CIT12][@CIT13] was an index of osteoblastic activity at the fracture site. In the test group, the radioactive[@CIT12] thymidine incorporation was significantly higher when compared with that in the control group. This is a definite evidence to suggest that ultrasound increases cell replication at the fracture site.

We tried to elucidate the mechanism by which ultrasound enhances healing by experimentally adding neurotransmitters at the fracture site in both the test group and controls. The radioactive thymidine incorporation was markedly increased in the test group with all the three different sets of neurotransmitters added.[@CIT11] Because the neurotransmitters act through their respective receptors, this might indicate that the receptor levels of these neurotransmitters were significantly increased at the fracture site by ultrasound administration.[@CIT14]

Thus, we postulate that ultrasound enhances fracture healing by increasing the receptor activity of neurotransmitters and hence the neurotransmitter activity at the fracture site. This also indicates that neurotransmitters play a role in inducing fracture healing. How neurotransmitters act at the molecular or subcellular level in enhancing the healing process remains to be studied in detail. Also the present study has to be supplemented by further studies in larger populations to authenticate the proposed mechanism by which ultrasound induces fracture healing. In the light of the concrete base thus achieved, this could pave the way for an entirely new frontier in fracture management and impetus for further research.

C[ONCLUSION]{.smallcaps} {#sec1-5}
========================

We conclude that low-intensity, pulsed ultrasound acts by upregulating the receptor activity of neurotransmitters at the fracture site, which probably enhances fracture healing.
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